SCA Pharmaceuticals Recalls Subpotent Vasopressin Injection Bags
SCA Pharmaceuticals is recalling 654 bags of Vasopressin 20 Units in 0.9% Sodium Chloride because the drug was subpotent.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score per the rubric, as it involves a subpotent drug that could result in serious temporary or medically reversible health consequences.
Plain-English summary
SCA Pharmaceuticals, Inc. is voluntarily recalling 654 bags of Vasopressin 20 Units added to 0.9% Sodium Chloride 100 mL, Single Dose Container. The recall was initiated on December 14, 2020, and was classified as Class II by the FDA. The reason for the recall is that the drug was found to be subpotent, meaning it contained less than the labeled amount of the active ingredient.
The affected product is distributed nationwide in the United States. Specific lots involved in the recall are 1120025012 (expiration date 01/13/2021), 1120025015 (expiration date 01/15/2021), and 1120025272 (expiration date 01/28/2021). The recall status is currently terminated as of September 23, 2021.
Healthcare providers and patients should check their inventory for these specific lot numbers and expiration dates. If the product is found, it should be quarantined and returned to the manufacturer or disposed of according to local regulations. The FDA has not reported any illnesses or injuries associated with this recall.
The recalled product
- Product
- Vasopressin 20 Units added to 0.9% Sodium Chloride 100 mL Rx Only, Single Dose Container, SCA Pharmaceuticals 8821 Knoedl Ct. Little Rock, AR 72205 Bar Code 70004093232
- Manufacturer
- SCA Pharmaceuticals, Inc.
- Category
- Drug — Injectable
- Hazard
- Affected units
- 654
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lots: 1120025012 BUD: 01/13/2021
- 1120025015 BUD: 01/15/2021
- 1120025272 BUD: 01/28/2021
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · SCA Pharmaceuticals, Inc.
See all →- SevereSCA Pharmaceuticals Recalls Furosemide Injection Bags Due to Precipitate
FDA (Drugs) · 2018-09-19
Same hazard · subpotent drug
See all →- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- ModerateAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02